PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

227 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
81.
Kundrát, P. et al.: Individual variability in doses to contralateral breast from tangential breast-cancer radiotherapy follows from variations in minimum breast distance. Strahlenther. Onkol. 195, S82-S82 (2019)
82.
Nguyen, L. ; Schilling, D. ; Dobiasch, S. ; Schmid, T.E. & Combs, S.E.: Radioresistant pancreatic cancer cell lines show lower levels of reactive oxygen species and higher DNA repair capacity. Strahlenther. Onkol. 195, S164-S164 (2019)
83.
Osterode, E.* et al.: Evaluation of CD44v6 targeting strategies in HNSCC. Strahlenther. Onkol. 195, S176-S176 (2019)
84.
Peeken, J.C. et al.: Deep learning derived tumor infiltration maps for personalized target definition in Glioblastoma radiotherapy. Strahlenther. Onkol. 195, S114-S114 (2019)
85.
Piehlmaier, D. et al.: In-vitro and in-vivo characterization of a glioblastoma cell line panel. Strahlenther. Onkol. 195, S63-S64 (2019)
86.
Sahay, J.* ; Schilling, D. ; Combs, S.E. & Gehrmann, M.*: Exosomes from mistletoe extract treated breast cancer cells to stimulate immune cells. Strahlenther. Onkol. 195, S148-S148 (2019)
87.
Scharl, S.* et al.: Cavity volume changes after surgery of abrain metastasisconsequences for stereotactic radiation therapy. Strahlenther. Onkol. 195, 207-217 (2019)
88.
Schilling, D. ; Wank, M. ; Reindl, J.* ; Schmid, T.E. & Combs, S.E.: Development of a cell culture system for irradiation with high LET alpha particles under hypoxic conditions. Strahlenther. Onkol. 195, S90-S90 (2019)
89.
Schmal, Z.* et al.: DNA damage accumulation during fractionated low-dose radiation compromises hippocampal neurogenesis. Strahlenther. Onkol. 195, S90-S90 (2019)
90.
Schmid, T.E. et al.: Biological interaction of ionizing irradiation with a static magnetic field (SMF). Strahlenther. Onkol. 195, S89-S89 (2019)
91.
Schnoeller, L.* et al.: In-depth characterization of radiation response in a human glioblastoma cell line panel. Strahlenther. Onkol. 195, S120-S121 (2019)
92.
Schötz, U. et al.: Inherent resistance of head and neck tumors: Cellular senescence and associated cyokine production as key mechanisms in vitro and in vivo. Strahlenther. Onkol. 195, S76-S76 (2019)
93.
Schrickel, F. et al.: The individual invasive properties of patient-derived primary GBM cells. Strahlenther. Onkol. 195, S168-S169 (2019)
94.
Siegmann, A. et al.: New insights into dose-rate effects (FLASH) on clonogenic cell survival of tumor and normal cell lines. Strahlenther. Onkol. 195, S174-S175 (2019)
95.
Simonetto, C. et al.: Longitudinal atherosclerotic changes in patients with hypopharyngeal carcinoma after radio (Chemo) therapy. Strahlenther. Onkol. 195, S128-S128 (2019)
96.
Straube, C. ; Shiban, E.* ; Meyer, B.* & Combs, S.E.: Radiochirurgie und operative neurovaskuläre Dekompression annähernd gleichwertig beider Behandlung von Trigeminusneuralgien. Strahlenther. Onkol. 195, 688-690 (2019)
97.
Unger, K. et al.: Validation of a 4-miRNA prognosticator allowing for improved risk stratification of glioblastoma patients in combination with MGMT promoter methylation status. Strahlenther. Onkol. 195, S63-S63 (2019)
98.
Vogel, M.M. et al.: Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy. Strahlenther. Onkol. 195, 131-144 (2019)
99.
Vogel, M.M.E.* et al.: Development of a prognostic Risk Classification for biochemical Recurrence after PSMA-PET-based Radiotherapy in Patients with oligometastatic Prostate Cancer. Strahlenther. Onkol. 195, S30-S31 (2019)
100.
Voglhuber, T.* ; Kessel, K.A. ; Oechsner, M.* & Combs, S.E.: Patterns of care and outcome analysis of stereotactic radiotherapy for patients with adrenal metastases. Strahlenther. Onkol. 195, S39-S39 (2019)